Leishmaniasis.
Desjeux
Philippe
P
D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007300:Insect Control / Q000379:methods; D007891:Leishmania / Q000187:drug effects / Q000235:genetics*; D007896:Leishmaniasis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology; D010303:Paromomycin / Q000494:pharmacology / Q000627:therapeutic use*; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D016052:Protozoan Vaccines
D000981:Antiprotozoal Agents; D016052:Protozoan Vaccines; D010767:Phosphorylcholine; C039128:miltefosine; D010303:Paromomycin